MentionFox
Home › funding signals › Transcarent, Inc.
Form D · on the record

Transcarent — $481M Form D filing, April 2025

Before you sell to, join or invest in Transcarent, Inc.

MentionFox check on Transcarent, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/transcarent-inc-form-d-25000001

Check Transcarent, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Transcarent, Inc.?

Based on the record MentionFox holds for this company. No flag is not a clearance.

Transcarent, Inc. filed a Form D with the Securities and Exchange Commission on 2025-04-22.

Transcarent, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 22, 2025. The filing reports $481M sold. Its industry group is Other Health Care. It names Glen Tullman (Executive Officer, Director), Lee Shapiro (Executive Officer, Director), Holly Maloney (Director) (SEC Form D, April 22, 2025).

Hemant Taneja is also named on 6 other Form D filings ↓

Is this your company?

Key facts

Run the free check on Transcarent, Inc. →

Sell to companies like Transcarent, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Transcarent, Inc.

New Form D on file · 2025-04-22 · the record

$481M
raise on the record
D
filing
33
investors in
COLORADO
based
Open the record →

What the record says

FilingForm D
Filed2025-04-22
Industry groupOther Health Care
Entity typeCorporation
Incorporated inDELAWARE
BasedDENVER, COLORADO
CIK2065307
Accession0002065307-25-000001

Pitching, partnering or investing alongside them? See who really runs and owns Transcarent, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Transcarent, Inc., from the filings we hold.

The people on this filing

More raises like this

Other Health Care raises by companies based in Colorado, filed within 90 days of this one, largest first.

What do you want to do with Transcarent, Inc.?

Get the full cited report on Transcarent, Inc.

What the filing shows about Transcarent, Inc.

  • 33 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Transcarent, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Transcarent, Inc.'s address as 4700 S. Syracuse Street, Suite 900, Denver, CO 80237.

Keep digging

Who else raised the same week in health care

What the filing says

  • Offered: $699,999,999. Sold: $480,999,962. Left to sell: $219,000,037. (filing)
  • Investors: 33 had already invested. (filing)
  • Date of first sale: April 7, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Transcarent, Inc. See pricing

Is Transcarent, Inc. a real, registered company?

Transcarent, Inc. is a registered filer with the SEC (CIK 2065307) and has filed since 2025-04-22. 1 filing is on record, the latest on 2025-04-22.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Transcarent, Inc.?

Transcarent, Inc.'s Form D of 2025-04-22 names Glen Tullman, Lee Shapiro, Holly Maloney and 4 more as its officers, directors or promoters.

How much has Transcarent, Inc. raised?

Its new offerings report $481M sold across 1 offering, as its own filings state.

Other Health Care · by week

Trailing twelve months. 863 filings in Other Health Care, totalled by week.

Want the whole picture on Transcarent, Inc.?

What the filing shows about Transcarent, Inc.

  • 33 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Transcarent, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Transcarent, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Transcarent, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-04 (transcarent.com).

RSS

Tools for this story

Each opens in a new tab, filled in for Transcarent, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Transcarent, Inc.: Raised $481M, Form D filed 2025-04-22
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/transcarent-inc-form-d-25000001
Last updated 2026-11-04
Primary record: SEC filing 1 · SEC filing 2
Transcarent raised $481M — SEC Form D filing, April 2025. MentionFox, 2026-11-04. https://mentionfox.com/funding/transcarent-inc-form-d-25000001